Atrial natriuretic peptide reduces hepatic ischemia-reperfusion injury in rabbits

Takashige Yamada, Yoshifumi Kotake, Hiromasa Nagata, Junzo Takeda

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Purpose: Atrial natriuretic peptide (ANP) has been known to be protective against hepatic ischemia/reperfusion injury. The purpose of this study was to verify the hypothesis that ANP conserves microvascular circulation and reduces ischemia-reperfusion injury in the in vivo rabbit model. Methods: With IRB approval, 30 male Japanese white rabbits under pentobarbital anesthesia were studied. These animals were randomly assigned to the following three groups (n = 10 each): control, ANP, and sham group. Animals in the ANP group received continuous infusion of ANP at 0.1 μg/kg/min throughout the study period. Animals in control and ANP groups underwent 90 min of partial hepatic ischemia by clamping the right hepatic artery and portal vein. Descending aortic blood flow (AoF) was monitored with a transit-time ultrasound flowmeter. Hepatic tissue microvascular blood flow (HTBF) at both right (ischemic) and left (nonischemic) lobe was intermittently evaluated with the hydrogen clearance method. After 180 min of reperfusion, hepatic injury was determined with serum AST and ALT. Galactose clearance of reperfused right lobe was also measured as an indicator of hepatic metabolic function. Histopathological change and the number of apoptotic hepatocytes were also evaluated. Results: Systemic hemodynamic data including mean arterial pressure, heart rate, and AoF did not differ among the three groups during the study period. ANP attenuated ischemia-induced right HTBF decrease. ANP also suppressed histopathological degeneration, apoptosis, and decline in galactose clearance after reperfusion. Conclusions: ANP attenuated hepatic microvascular dysfunction and hepatocyte injury after reperfusion without significant hemodynamic change.

Original languageEnglish
Pages (from-to)901-908
Number of pages8
JournalJournal of Anesthesia
Volume27
Issue number6
DOIs
Publication statusPublished - 2013 Dec

Fingerprint

Atrial Natriuretic Factor
Reperfusion Injury
Rabbits
Liver
Galactose
Hepatocytes
Ischemia
Hemodynamics
Flowmeters
Hepatic Veins
Research Ethics Committees
Hepatic Artery
Pentobarbital
Portal Vein
Constriction
Reperfusion
Hydrogen
Arterial Pressure
Anesthesia
Heart Rate

Keywords

  • Atrial natriuretic peptide
  • Ischemia-reperfusion
  • Liver injury
  • Tissue microvascular blood flow

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Atrial natriuretic peptide reduces hepatic ischemia-reperfusion injury in rabbits. / Yamada, Takashige; Kotake, Yoshifumi; Nagata, Hiromasa; Takeda, Junzo.

In: Journal of Anesthesia, Vol. 27, No. 6, 12.2013, p. 901-908.

Research output: Contribution to journalArticle

@article{e63c0830a858410ba942b78f13a64108,
title = "Atrial natriuretic peptide reduces hepatic ischemia-reperfusion injury in rabbits",
abstract = "Purpose: Atrial natriuretic peptide (ANP) has been known to be protective against hepatic ischemia/reperfusion injury. The purpose of this study was to verify the hypothesis that ANP conserves microvascular circulation and reduces ischemia-reperfusion injury in the in vivo rabbit model. Methods: With IRB approval, 30 male Japanese white rabbits under pentobarbital anesthesia were studied. These animals were randomly assigned to the following three groups (n = 10 each): control, ANP, and sham group. Animals in the ANP group received continuous infusion of ANP at 0.1 μg/kg/min throughout the study period. Animals in control and ANP groups underwent 90 min of partial hepatic ischemia by clamping the right hepatic artery and portal vein. Descending aortic blood flow (AoF) was monitored with a transit-time ultrasound flowmeter. Hepatic tissue microvascular blood flow (HTBF) at both right (ischemic) and left (nonischemic) lobe was intermittently evaluated with the hydrogen clearance method. After 180 min of reperfusion, hepatic injury was determined with serum AST and ALT. Galactose clearance of reperfused right lobe was also measured as an indicator of hepatic metabolic function. Histopathological change and the number of apoptotic hepatocytes were also evaluated. Results: Systemic hemodynamic data including mean arterial pressure, heart rate, and AoF did not differ among the three groups during the study period. ANP attenuated ischemia-induced right HTBF decrease. ANP also suppressed histopathological degeneration, apoptosis, and decline in galactose clearance after reperfusion. Conclusions: ANP attenuated hepatic microvascular dysfunction and hepatocyte injury after reperfusion without significant hemodynamic change.",
keywords = "Atrial natriuretic peptide, Ischemia-reperfusion, Liver injury, Tissue microvascular blood flow",
author = "Takashige Yamada and Yoshifumi Kotake and Hiromasa Nagata and Junzo Takeda",
year = "2013",
month = "12",
doi = "10.1007/s00540-013-1643-3",
language = "English",
volume = "27",
pages = "901--908",
journal = "Journal of Anesthesia",
issn = "0913-8668",
publisher = "Springer Japan",
number = "6",

}

TY - JOUR

T1 - Atrial natriuretic peptide reduces hepatic ischemia-reperfusion injury in rabbits

AU - Yamada, Takashige

AU - Kotake, Yoshifumi

AU - Nagata, Hiromasa

AU - Takeda, Junzo

PY - 2013/12

Y1 - 2013/12

N2 - Purpose: Atrial natriuretic peptide (ANP) has been known to be protective against hepatic ischemia/reperfusion injury. The purpose of this study was to verify the hypothesis that ANP conserves microvascular circulation and reduces ischemia-reperfusion injury in the in vivo rabbit model. Methods: With IRB approval, 30 male Japanese white rabbits under pentobarbital anesthesia were studied. These animals were randomly assigned to the following three groups (n = 10 each): control, ANP, and sham group. Animals in the ANP group received continuous infusion of ANP at 0.1 μg/kg/min throughout the study period. Animals in control and ANP groups underwent 90 min of partial hepatic ischemia by clamping the right hepatic artery and portal vein. Descending aortic blood flow (AoF) was monitored with a transit-time ultrasound flowmeter. Hepatic tissue microvascular blood flow (HTBF) at both right (ischemic) and left (nonischemic) lobe was intermittently evaluated with the hydrogen clearance method. After 180 min of reperfusion, hepatic injury was determined with serum AST and ALT. Galactose clearance of reperfused right lobe was also measured as an indicator of hepatic metabolic function. Histopathological change and the number of apoptotic hepatocytes were also evaluated. Results: Systemic hemodynamic data including mean arterial pressure, heart rate, and AoF did not differ among the three groups during the study period. ANP attenuated ischemia-induced right HTBF decrease. ANP also suppressed histopathological degeneration, apoptosis, and decline in galactose clearance after reperfusion. Conclusions: ANP attenuated hepatic microvascular dysfunction and hepatocyte injury after reperfusion without significant hemodynamic change.

AB - Purpose: Atrial natriuretic peptide (ANP) has been known to be protective against hepatic ischemia/reperfusion injury. The purpose of this study was to verify the hypothesis that ANP conserves microvascular circulation and reduces ischemia-reperfusion injury in the in vivo rabbit model. Methods: With IRB approval, 30 male Japanese white rabbits under pentobarbital anesthesia were studied. These animals were randomly assigned to the following three groups (n = 10 each): control, ANP, and sham group. Animals in the ANP group received continuous infusion of ANP at 0.1 μg/kg/min throughout the study period. Animals in control and ANP groups underwent 90 min of partial hepatic ischemia by clamping the right hepatic artery and portal vein. Descending aortic blood flow (AoF) was monitored with a transit-time ultrasound flowmeter. Hepatic tissue microvascular blood flow (HTBF) at both right (ischemic) and left (nonischemic) lobe was intermittently evaluated with the hydrogen clearance method. After 180 min of reperfusion, hepatic injury was determined with serum AST and ALT. Galactose clearance of reperfused right lobe was also measured as an indicator of hepatic metabolic function. Histopathological change and the number of apoptotic hepatocytes were also evaluated. Results: Systemic hemodynamic data including mean arterial pressure, heart rate, and AoF did not differ among the three groups during the study period. ANP attenuated ischemia-induced right HTBF decrease. ANP also suppressed histopathological degeneration, apoptosis, and decline in galactose clearance after reperfusion. Conclusions: ANP attenuated hepatic microvascular dysfunction and hepatocyte injury after reperfusion without significant hemodynamic change.

KW - Atrial natriuretic peptide

KW - Ischemia-reperfusion

KW - Liver injury

KW - Tissue microvascular blood flow

UR - http://www.scopus.com/inward/record.url?scp=84891484089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891484089&partnerID=8YFLogxK

U2 - 10.1007/s00540-013-1643-3

DO - 10.1007/s00540-013-1643-3

M3 - Article

VL - 27

SP - 901

EP - 908

JO - Journal of Anesthesia

JF - Journal of Anesthesia

SN - 0913-8668

IS - 6

ER -